Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 177, pseudogene (RN7SL177P)

Target
RN7SL177P
Molecular classification
Non-coding RNA, Pseudogene
01

Overview

RN7SL177P is a pseudogene located in the human genome, representing a truncated or mutated copy of the gene encoding 7SL RNA, a non-coding RNA component of the signal recognition particle (SRP)[1][7]. The **7SL RNA** serves as a scaffold within the SRP, which guides the cotranslational insertion of secretory proteins into the endoplasmic reticulum[5][3]. Unlike the genuine RN7SL1 gene (7SL RNA), RN7SL177P does not produce a functional RNA, nor does it participate directly in protein targeting or cellular signaling[1][7]. Most 7SL pseudogenes, including RN7SL177P, arose via reverse transcription and DNA integration and are not expressed or functional in normal cells[7]. There are currently no established disease roles, clinical relevance, or therapeutic implications for RN7SL177P. If you need information about the actual **functional 7SL RNA (RN7SL1)**, which plays an essential role in SRP-mediated protein targeting and is implicated in certain cancer pathways[5][3], refer to RN7SL1, not RN7SL pseudogenes.

Other names
RN7SL177P7SL RNA pseudogene 177
02

Biological functions

Other (Pseudogenes generally do not have direct biological functions, but rare pseudogene transcripts may influence gene regulation, mainly through competitive endogenous RNA effects, microRNA sponging, or RNA-binding protein interactions)
03

Disease associations

Other (There is no disease association established for RN7SL177P specifically; however, some pseudogenes are rarely implicated in cancer or gene regulation through ceRNA mechanisms, but this is not established for RN7SL177P)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 177, pseudogene (RN7SL177P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 177, pseudogene (RN7SL177P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call